Plate Nº 27 · recorded November 2, 2026
Health & Medicine ResearchReported finding
'Unhealthy' Diets Made Immunotherapy Work Better — in Mice
A McGill-led Nature study found some obesity-linked diets improved cancer immunotherapy in mice, hinting diet and gut bacteria jointly shape treatment response. Results are preliminary.
By Elena Vasquez3 min read685 words
In brief
- The study tested 12 different diets in mice; some obesity-linked diets improved responses to immune checkpoint inhibitors.
- Findings were published in Nature on November 2, 2026, by a McGill-led team under Daniela Quail.
- Immune checkpoint inhibitors help the immune system recognize and attack cancer cells.
- Researchers caution the results do not mean cancer patients should adopt obesity-promoting diets.
- Funders included the Canadian Institutes of Health Research, the Canadian Cancer Society and the Terry Fox Research Institute.
Some diets linked to weight gain made cancer immunotherapy work better in mice — a counterintuitive result published November 2, 2026, in Nature by a McGill University-led team. The finding challenges the simple assumption that healthy eating always helps cancer treatment, though the researchers stress it is no license to eat badly.
The study tested 12 different diets in mice, some of them associated with obesity. Several of those fattening diets improved how the animals responded to immune checkpoint inhibitors, a widely used class of immunotherapy drugs that help the immune system recognize and attack cancer cells. The benefit appeared even when the diets were consumed for relatively short periods.
The secret, the researchers believe, lies in the gut — specifically, in how food interacts with gut bacteria to strengthen the immune system's response to cancer.
What did the researchers actually find?
The core discovery is a partnership between two things doctors usually consider separately: the trillions of bacteria living in the digestive tract — collectively called the gut microbiome — and the food those bacteria feed on.
"There is a synergistic relationship between the bacteria that reside in our GI tract, and the food we eat," said Daniela Quail, Associate Professor in McGill's Department of Physiology and Principal Investigator at the Rosalind & Morris Goodman Cancer Institute, who co-led the research.
"Even with the right composition of bacteria in your gut, the foods you eat to nourish those populations can determine whether or not you respond to treatment," Quail said.
In plain terms: having the right gut bacteria isn't enough. What you feed them may decide whether the treatment works.
The senior research team included McGill scientist Logan Walsh and CR-CHUM collaborators Bertrand Routy and Arielle Elkrief. McGill PhD graduate Lysanne Desharnais was the study's lead author.
Why did 'unhealthy' diets help?
The results surprised the scientists themselves.
"Our findings were surprising because they highlighted a benefit of some obesogenic diets," Quail said. "That tells us the relationship between diet and cancer treatment is more complex than a simple message to eat healthy and exercise."
The caution here matters. The researchers emphasize that cancer patients should not adopt diets that promote obesity. Excess weight carries well-established health risks, and nothing in this study shows such diets would improve treatment in humans.
The goal is mechanistic, not dietary advice. The team wants to identify exactly which food-bacteria interactions drive the improved treatment response, so that safer ways to boost immunotherapy can eventually be developed.
Does this explain cancer's 'obesity paradox'?
The investigation grew out of a longstanding puzzle known as the "obesity paradox." Obesity generally raises both the risk of developing cancer and the risk of dying from it. Yet several studies have found that cancer patients with a higher body mass index (BMI) sometimes respond more favorably to immune checkpoint inhibitors.
The mouse results offer a possible explanation. If some obesity-associated diets improve immunotherapy response, the apparent treatment advantage seen in heavier patients may not stem from body weight itself. It could instead come from the combined effect of diet and gut bacteria on the immune system.
That reframes the paradox. The advantage isn't the obesity — it may be what certain diets do to the gut.
By uncovering these interactions, the researchers hope to reproduce the beneficial effects in new treatments without exposing patients to the health risks of obesity.
How solid are the findings?
This is a mouse study, and the limitations are real. Mice are not people, and the results do not demonstrate that any dietary change would improve cancer treatment in humans. The mechanisms remain to be fully mapped.
The work does, however, open a concrete research path: pin down which foods feed which bacteria, and how that shapes immune response to cancer.
Funding came from the Canadian Institutes of Health Research, the Canadian Cancer Society, the Terry Fox Research Institute, the Canada Foundation for Innovation, and philanthropic supporters including La Vie en Rose and the Bachynski Family Foundation. The paper, "Diet-microbiome synergy underlies obesity-associated immunotherapy efficacy," appears in Nature, volume 657.
via mcgill.ca (Original)
More from Elena Vasquez
Show full bio
Correspondent covering money, funding and market shifts around general science news at SciBeat.
288 articles
Nearby plates
- Some High-Fat Diets Boosted Immunotherapy in Mice, McGill Study Finds
- Keto Diet Raises Small-Intestine Tumor Risk in MIT Mouse Study
- Sugar May Amplify the Gut Damage Antibiotics Cause
- Skipping Sweets During Antibiotic Treatment May Protect Gut Microbiome
- IBD food reactions may stem from gut bacteria loss, study finds